Adenosine and epilepsy: From therapeutic rationale to new therapeutic strategies

Neuroscientist

Volumn 11, Issue 1, 2005, Pages 25-36

  Boison, Detlev ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Adenosine; Adenosine kinase; Astrogliosis; Cell therapy; Epilepsy; Seizure susceptibility

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 2 CHLORO 6 N CYCLOPENTYLADENOSINE; 2 HEXYNYL 5' N ETHYLCARBOXAMIDOADENOSINE; 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 5 IODOTUBERCIDIN; 5' NUCLEOTIDASE; 8 (4 SULFOPHENYL)THEOPHYLLINE; ADENOSINE; ADENOSINE 5' (N CYCLOPROPYLCARBOXAMIDE); ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE DEAMINASE; ADENOSINE KINASE; ADENOSINE KINASE INHIBITOR; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR STIMULATING AGENT; ADENOSINE TRANSPORT INHIBITOR; ADENOSYLHOMOCYSTEINASE; ADENYLATE CYCLASE; ANTICONVULSIVE AGENT; CALCIUM ION; CARBAMAZEPINE; G PROTEIN COUPLED RECEPTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; PHOSPHOLIPASE C; UNCLASSIFIED DRUG;

ANTICONVULSANT ACTIVITY; ASTROCYTOSIS; BIOENGINEERING; BRADYCARDIA; CELL TRANSPLANTATION; EPILEPSY; EPILEPTOGENESIS; HUMAN; HYPOTENSION; HYPOTHERMIA; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEDATION; SEIZURE SUSCEPTIBILITY; STEREOTAXIC SURGERY;

ADENOSINE; BRAIN; CELL TRANSPLANTATION; EPILEPSY; HOMEOSTASIS; HUMANS; MEMBRANE TRANSPORT MODULATORS; MEMBRANE TRANSPORT PROTEINS; MODELS, NEUROLOGICAL; NEURAL INHIBITION; NUCLEOSIDE TRANSPORT PROTEINS; RECEPTORS, PURINERGIC P1;

EID: 13544274000     PISSN: 10738584     EISSN: None     Source Type: Journal    
DOI: 10.1177/1073858404269112     Document Type: Review

References (61)

1. Angelatou F, Pagonopoulou O, Maraziotis T, Olivier A, Villemeure JG, Avoli M, and others. 1993. Upregulation of A1 adenosine receptors in human temporal lobe epilepsy: a quantitative autoradiographic study. Neurosci Lett 163:11-4.
2. Bengzon J, Kokaia Z, Elmér E, Nanobashvili A, Kokaia M, Lindvall O. 1997. Apoptosis and proliferation of dentate gyms neurons after single and intermittent limbic seizures. Proc Natl Acad Sci U S A 94:10432-7.
3. Berman RF, Fredholm BB, Aden U, O'Connor WT. 2000. Evidence for increased dorsal hippocampal adenosine release and metabolism during pharmacologically induced seizures in rats. Brain Res 872:44-53.
4. Boison D, Scheurer L, Tseng JL, Aebischer P, Mohler H. 1999. Seizure suppression in kindled rats by intraventricular grafting of an adenosine releasing synthetic polymer. Exp Neurol 160:164-74.
5. Boison D, Scheurer L, Zumsteg V, Rülicke T, Litynski P, Fowler B, and others. 2002. Neonatal hepatic steatosis by disruption of the adenosine kinase gene. Proc Natl Acad Sci U S A 99:6985-90.
6. Bontemps F, Van den Berghe G, Hers HG. 1983. Evidence for a substrate cycle between AMP and adenosine in isolated hepatocytes. Proc Natl Acad Sci U S A 80:2829-33.
7. Brustle O, Jones KN, Learish RD, Karram K, Choudhary K, Wiestler OD, and others. 1999. Embryonic stem cell-derived glial precursors: a source of myelinating transplants. Science 285:754-6.
8. Cass CE, Young JD, Baldwin SA, Cabrita MA, Graham KA, Griffiths M, and others. 1999. Nucleoside transporters of mammalian cells. Pharm Biotechnol 12:313-52.
9. Chakraborty A, Das I, Datta R, Sen B, Bhattacharyya D, Mandal C, and others. 2002. A single-domain cyclophilin from Leishmania donovani reactivates soluble aggregates of adenosine kinase by isomerase-independent chaperone function. J Biol Chem 277:47451-60.
10. De Sarro G, De Sarro A, Di Paola ED, Bertorelli R. 1999. Effects of adenosine receptor agonists and antagonists on audiogenic seizure-sensible DBA/2 mice. Eur J Pharmacol 371:137-45.
11. Devinsky O. 1999. Patients with refractory seizures. N Engl J Med 340:1565-70.
12. Dragunow M, Robertson HA. 1987. 8-cyclopentyl 1,3-dimethylxanthine prolongs epileptic seizures in rats. Brain Res 417:377-9.
13. Dunwiddie TV. 1999. Adenosine and suppression of seizures. Adv Neurol 79:1001-10.
14. Dunwiddie TV, Diao L, Kim HO, Jiang JL, Jacobson KA. 1997. Activation of hippocampal adenosine A3 receptors produces a desensitization of A1 receptor-mediated responses in rat hippocampus. J Neurosci 17:607-14.
15. Dunwiddie TV, Masino SA. 2001. The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci 24:31-55.
16. During MJ, Spencer DD. 1992. Adenosine: a potential mediator of seizure arrest and postictal refractoriness. Ann Neurol 32:618-24
17. Ekonomou A, Sperk G, Kostopoulos G, Angelatou F. 2000. Reduction of A1 adenosine receptors in rat hippocampus after kainic acid-induced limbic seizures. Neurosci Lett 284:49-52.
18. Etherington LA, Frenguelli BG. 2004. Endogenous adenosine modulates epileptiform activity in rat hippocampus in a receptor subtype-dependent manner. Eur J Neurosci 19:2539-50.
19. Fedele DE, Koch P, Scheurer L, Simpson EM, Möhler H, Brüstle O, Boison D. 2004. Engineering embryonic stem cell derived glia for adenosine delivery. Neurosci Lett 370:160-5.Foldvary N, Bingaman WE, Wyllie E. 2001. Surgical treatment of epilepsy. Neurol Clin 19:491-515.
20. Fedele DE, Koch P, Scheurer L, Simpson EM, Möhler H, Brüstle O, Boison D. 2004. Engineering embryonic stem cell derived glia for adenosine delivery. Neurosci Lett 370:160-5.Foldvary N, Bingaman WE, Wyllie E. 2001. Surgical treatment of epilepsy. Neurol Clin 19:491-515.
21. Fredholm BB, Battig K, Holmen J, Nehlig A, Zvartau EE. 1999. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 51:83-133.
22. Fredholm BB, Ijzerman AP, Jacobson KA, Klotz KN, Linden J. 2001. International Union of Pharmacology. XXV Nomenclature and classification of adenosine receptors. Pharmacol Rev 53:527-52.
23. Glass M, Faull RL, Bullock JY, Jansen K, Mee EW, Walker EB, and others. 1996. Loss of A1 adenosine receptors in human temporal lobe epilepsy. Brain Res 710:56-68.
24. Gouder N, Fritschy JM, Boison D. 2003. Seizure suppression by adenosine A1 receptor activation in a mouse model of pharmacoresistant epilepsy. Epilepsia 44:877-85.
25. Gouder N, Scheurer L, Fritschy J-M, Boison D. 2004. Overexpression of adenosine kinase in epileptic hippocampus contributes to epileptogenesis. J Neurosci 24:692-701.
26. Huber A, Güttinger M, Möhler H, Boison D. 2002. Seizure suppression by adenosine A2A receptor activation in a rat model of audiogenic brainstem epilepsy. Neurosci Lett 329:289-92.
27. Huber A, Padrun V, Deglon N, Aebischer P, Mohler H, Boison D. 2001. Grafts of adenosine-releasing cells suppress seizures in kindling epilepsy. Proc Natl Acad Sci U S A 98:7611-6.
28. Jacobson KA, von Lubitz DKJE, Daly JW, Fredholm BB. 1996. Adenosine receptor ligands: differences with acute versus chronic treatment. Trends Pharmacol Sci 17:108-13.
29. Jallon P. 1997. The problem of intractability: the continuing need for new medical therapies in epilepsy. Epilepsia 38:S37-S42.
30. Klinger M, Freissmuth M, Nanoff C. 2002. Adenosine receptors: G protein-mediated signalling and the role of accessory proteins. Cell Signal 14:99-108.
31. Kostopoulos G, Drapeau C, Avoli M, Olivier A, Villemeure JG. 1989. Endogenous adenosine can reduce epileptiform activity in the human epileptogenic cortex maintained in vitro. Neurosci Lett 106:119-24.
32. Kowaluk EA, Jarvis MF. 2000. Therapeutic potential of adenosine kinase inhibitors. Expert Opin Investig Drugs 9:551-64.
33. Li JY, Boado RJ, Pardridge WM. 2001. Cloned blood-brain barrier adenosine transporter is identical to the rat concentrative Na+ nucleoside cotransporter CNT2. J Cereb Blood Flow Metab 21:929-36.
34. Loscher W, Potschka H. 2002. Role of multidrug transporters in pharmacoresistance to antiepileptic drugs. J Pharmacol Exp Ther 301:7-14.
35. Malhotra J, Gupta YK. 1997. Effect of adenosine receptor modulation on pentylenetetrazole-induced seizures in rats. Br J Pharmacol 120:282-8.
36. Masino SA, Dunwiddie TV. 1999. Temperature-dependent modulation of excitatory transmission in hippocampal slices is mediated by extracellular adenosine. J Neurosci 19:1932-9.
37. Mathews II, Erion MD, Ealick SE. 1998. Structure of human adenosine kinase at 1.5 angstrom resolution. Biochemistry 37:15607-20.
38. McNally T, Helfrich RJ, Cowart M, Dorwin SA, Meuth JL, Idler KB, and others. 1997. Cloning and expression of the adenosine kinase gene from rat and human tissues. Biochem Biophys Res Commun 231:645-50.
39. Monopoli A, Conti A, Dionisotti S, Casati C, Camaioni E, Cristalli G, and others. 1994. Pharmacology of the highly selective A1 adenosine receptor agonist 2-chloro-N6-cyclopentyladenosine. Arzneimittelforschung 44:1305-12.
40. Moore KA, Nicoll RA, Schmitz D. 2003. Adenosine gates synaptic plasticity at hippocampal mossy fiber synapses. Proc Natl Acad Sci U S A 100:14397-402.
41. Nilsen KE, Cock HR. 2004. Focal treatment for refractory epilepsy: hope for the future? Brain Res Brain Res Rev 44:141-53.
42. Ojemann GA. 1997. Treatment of temporal lobe epilepsy. Ann Rev Med 48:317-28.
43. Pak MA, Haas HL, Decking UKM, Schrader J. 1994. Inhibition of adenosine kinase increases endogenous adenosine and depresses neuronal activity in hippocampal slices. Neuropharmacol 33:1049-53.
44. Pardridge WM, Yoshikawa T, Kang Y-S, Miller LP. 1994. Blood-brain barrier transport and brain metabolism of adenosine and adenosine analogs. J Pharm Exp Ther 268:14-8.
45. Pedata F, Corsi C, Melani A, Bordoni F, Latini S. 2001. Adenosine extracellular brain concentrations and role of A2A receptors in ischemia. Ann N Y Acad Sci 939:74-84.
46. Rebola N, Coelho JE, Costenla AR, Lopes LV, Parada A, Oliveira CR, and others. 2003. Decrease of adenosine A1 receptor density and of adenosine neuromodulation in the hippocampus of kindled rats. Eur J Neurosci 18:820-8.
47. Regis J, Bartolomei F, Rey M, Hayashi M, Chauvel P, Peragut JC. 2000. Gamma knife surgery for mesial temporal lobe epilepsy. J Neurosurg 93(Suppl 3): 141-6.
48. Riban V, Bouilleret V, Pham-Le BT, Fritschy JM, Marescaux C, Depaulis A. 2002. Evolution of hippocampal epileptic activity during the development of hippocampal sclerosis in a mouse model of temporal lobe epilepsy. Neuroscience 112:101-11.
49. Ribeiro JA, Sebastiao AM, de Mendonca A. 2003. Adenosine receptors in the nervous system: pathophysiological implications. Prog Neurobiol 68:377-92.
50. Sabers A, Gram L. 2000. Newer anticonvulsants: comparative review of drug interactions and adverse effects. Drugs 60:23-33.
51. Sisodiya SM, Lin WR, Harding BN, Squier MV, Thom M. 2002. Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy. Brain 125:22-31.
52. Stein AG, Eder HG, Blum DE, Drachev A, Fisher RS. 2000. An automated drug delivery system for focal epilepsy. Epilepsy Res 39:103-14.
53. Takigawa T, Alzheimer C. 2002. Phasic and tonic attenuation of EPSPs by inward rectifier K+ channels in rat hippocampal pyramidal cells. J Physiol 539:67-75.
54. Toma JG, Akhavan M, Fernandes KJL, Barnabö-Heider F, Sadikot A, Kaplan DR, and others. 2001. Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat Cell Biol 3:778-84.
55. Uthman BM. 2000. Vagus nerve stimulation for seizures. Arch Med Res 31:300-3.
56. Vanore G, Giraldez L, Rodriguez de Lores Arnaiz G, Girardi E. 2001. Seizure activity produces differential changes in adenosine A1 receptors within rat hippocampus. Neurochem Res 26:225-30.
57. Wiesner JB, Ugarkar BG, Castellino AJ, Barankiewicz J, Dumas DP, Gruber HE, and others. 1999. Adenosine kinase inhibitors as a novel approach to anticonvulsant therapy. J Pharmacol Exp Ther 289:1669-77.
58. Young D, Dragunow M. 1994. Status epilepticus may be caused by loss of adenosine anticonvulsant mechanisms. Neuroscience 58:245-61.
59. Zhang G, Franklin PH, Murray TF. 1993. Manipulation of endogenous adenosine in the rat prepiriform cortex modulates seizure susceptibility. J Pharmacol Exp Ther 264:1415-24.
60. 1-receptors underlies anticonvulsant effect of CGS21680. Eur J Pharmacol 255:239-43.
61. Zumsteg V, Boison D. 2002. The use of real-time PCR with fluorogenic probes for the rapid selection of mutant neuroectodermal grafts. J Neurosci Meth 120:85-94.